343 ETH (Benazepril 20 mg)
Pill imprint 343 ETH has been identified as Benazepril hydrochloride 20 mg.
Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; left ventricular dysfunction and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 343 ETH
- 20 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Ethex Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- carnauba wax
silicon dioxide colloidal
ferric oxide black
yellow iron oxide
|NDC Code||Manufacturer / Repackager|
|54569-5669||A-S Medication Solutions, LLC (repackager)|
|66336-0691||Dispensing Solutions Inc. (repackager)|
|68071-0146||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about benazepril
- Other brands: Lotensin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.